Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 USD | +3.11% | +4.19% | +0.51% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
Financials (USD)
Sales 2024 * | 37.9M | Sales 2025 * | 35.29M | Capitalization | 178M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -29M | EV / Sales 2024 * | 4.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.05 x |
P/E ratio 2024 * |
-15.3
x | P/E ratio 2025 * |
-7.37
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | +3.11% | ||
1 week | +0.51% | ||
Current month | +3.11% | ||
1 month | -22.87% | ||
3 months | -17.43% | ||
6 months | +161.84% | ||
Current year | +0.51% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 1.99 | +3.11% | 333,399 |
24-04-30 | 1.93 | -2.53% | 274,515 |
24-04-29 | 1.98 | +3.13% | 277,619 |
24-04-26 | 1.92 | +1.05% | 326,190 |
24-04-25 | 1.9 | -0.52% | 268,596 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.51% | 173M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- CGEN Stock